CN107105747A - 包含间歇灭菌的乳酸菌死菌体作为有效成分的用于皮肤保湿或改善皱纹的组合物 - Google Patents
包含间歇灭菌的乳酸菌死菌体作为有效成分的用于皮肤保湿或改善皱纹的组合物 Download PDFInfo
- Publication number
- CN107105747A CN107105747A CN201580061120.5A CN201580061120A CN107105747A CN 107105747 A CN107105747 A CN 107105747A CN 201580061120 A CN201580061120 A CN 201580061120A CN 107105747 A CN107105747 A CN 107105747A
- Authority
- CN
- China
- Prior art keywords
- lactic acid
- acid bacteria
- keeping
- skin
- skin moisture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title claims abstract description 218
- 241000894006 Bacteria Species 0.000 title claims abstract description 116
- 239000004310 lactic acid Substances 0.000 title claims abstract description 109
- 235000014655 lactic acid Nutrition 0.000 title claims abstract description 109
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 title claims abstract description 82
- 230000001954 sterilising effect Effects 0.000 title claims abstract description 79
- 238000004659 sterilization and disinfection Methods 0.000 title claims abstract description 74
- 239000000203 mixture Substances 0.000 title claims abstract description 51
- 230000037303 wrinkles Effects 0.000 title claims abstract description 49
- 239000004480 active ingredient Substances 0.000 title claims abstract description 24
- 230000006872 improvement Effects 0.000 title claims abstract description 23
- 206010040844 Skin exfoliation Diseases 0.000 claims abstract description 3
- 239000002537 cosmetic Substances 0.000 claims description 28
- 235000013305 food Nutrition 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 18
- 238000000855 fermentation Methods 0.000 claims description 15
- 230000004151 fermentation Effects 0.000 claims description 15
- 230000006870 function Effects 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 12
- 241000186660 Lactobacillus Species 0.000 claims description 8
- 229940039696 lactobacillus Drugs 0.000 claims description 8
- 239000003921 oil Substances 0.000 claims description 8
- 239000008194 pharmaceutical composition Substances 0.000 claims description 8
- 241000186000 Bifidobacterium Species 0.000 claims description 7
- 241000194036 Lactococcus Species 0.000 claims description 7
- 241000192001 Pediococcus Species 0.000 claims description 7
- 241000194017 Streptococcus Species 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- -1 creme Substances 0.000 claims description 7
- 239000012071 phase Substances 0.000 claims description 7
- 241000588807 Bordetella Species 0.000 claims description 6
- 241000194033 Enterococcus Species 0.000 claims description 6
- 230000001580 bacterial effect Effects 0.000 claims description 6
- 241000192132 Leuconostoc Species 0.000 claims description 5
- 239000003755 preservative agent Substances 0.000 claims description 5
- 230000002335 preservative effect Effects 0.000 claims description 5
- 239000004094 surface-active agent Substances 0.000 claims description 5
- 239000008346 aqueous phase Substances 0.000 claims description 4
- 230000008859 change Effects 0.000 claims description 4
- 239000000839 emulsion Substances 0.000 claims description 4
- 238000009472 formulation Methods 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 4
- 150000002632 lipids Chemical class 0.000 claims description 4
- 239000002270 dispersing agent Substances 0.000 claims description 3
- 239000000975 dye Substances 0.000 claims description 3
- 239000003381 stabilizer Substances 0.000 claims description 3
- 239000002562 thickening agent Substances 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 239000004902 Softening Agent Substances 0.000 claims description 2
- 239000012190 activator Substances 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 125000002091 cationic group Chemical group 0.000 claims description 2
- 239000002738 chelating agent Substances 0.000 claims description 2
- 239000000945 filler Substances 0.000 claims description 2
- 239000004088 foaming agent Substances 0.000 claims description 2
- 239000003349 gelling agent Substances 0.000 claims description 2
- 230000036541 health Effects 0.000 claims description 2
- 230000000873 masking effect Effects 0.000 claims description 2
- 229910021645 metal ion Inorganic materials 0.000 claims description 2
- 239000004530 micro-emulsion Substances 0.000 claims description 2
- 239000003094 microcapsule Substances 0.000 claims description 2
- 239000012875 nonionic emulsifier Substances 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 239000000049 pigment Substances 0.000 claims description 2
- 239000003340 retarding agent Substances 0.000 claims description 2
- 239000002884 skin cream Substances 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 239000000375 suspending agent Substances 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 2
- 239000000341 volatile oil Substances 0.000 claims description 2
- 230000010148 water-pollination Effects 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims 1
- 235000013376 functional food Nutrition 0.000 claims 1
- 239000007800 oxidant agent Substances 0.000 claims 1
- 230000001590 oxidative effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 102000004169 proteins and genes Human genes 0.000 abstract description 9
- 108090000623 proteins and genes Proteins 0.000 abstract description 9
- 230000014509 gene expression Effects 0.000 abstract description 8
- 230000006378 damage Effects 0.000 abstract description 3
- 230000008591 skin barrier function Effects 0.000 abstract description 3
- 230000001678 irradiating effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 67
- 238000002360 preparation method Methods 0.000 description 17
- 235000014633 carbohydrates Nutrition 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 150000001720 carbohydrates Chemical class 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 101000990902 Homo sapiens Matrix metalloproteinase-9 Proteins 0.000 description 6
- 102100030412 Matrix metalloproteinase-9 Human genes 0.000 description 6
- 241001052560 Thallis Species 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 230000003020 moisturizing effect Effects 0.000 description 6
- 240000001046 Lactobacillus acidophilus Species 0.000 description 5
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 5
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 5
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 235000019219 chocolate Nutrition 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 230000036559 skin health Effects 0.000 description 4
- 235000013599 spices Nutrition 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical compound CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 229920002674 hyaluronan Polymers 0.000 description 3
- 230000000415 inactivating effect Effects 0.000 description 3
- 239000000787 lecithin Substances 0.000 description 3
- 235000010445 lecithin Nutrition 0.000 description 3
- 229940067606 lecithin Drugs 0.000 description 3
- 235000012149 noodles Nutrition 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000001960 triggered effect Effects 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- AXPZIVKEZRHGAS-UHFFFAOYSA-N 3-benzyl-5-[(2-nitrophenoxy)methyl]oxolan-2-one Chemical compound [O-][N+](=O)C1=CC=CC=C1OCC1OC(=O)C(CC=2C=CC=CC=2)C1 AXPZIVKEZRHGAS-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- 244000077995 Coix lacryma jobi Species 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 235000015895 biscuits Nutrition 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 235000021329 brown rice Nutrition 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 230000003862 health status Effects 0.000 description 2
- 235000001497 healthy food Nutrition 0.000 description 2
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 2
- 229940099552 hyaluronan Drugs 0.000 description 2
- 235000015243 ice cream Nutrition 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 235000019488 nut oil Nutrition 0.000 description 2
- 239000010466 nut oil Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
- 229960003415 propylparaben Drugs 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- 235000015192 vegetable juice Nutrition 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- KVZLHPXEUGJPAH-UHFFFAOYSA-N 2-oxidanylpropanoic acid Chemical compound CC(O)C(O)=O.CC(O)C(O)=O KVZLHPXEUGJPAH-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 244000060701 Kaempferia pandurata Species 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 102000006463 Talin Human genes 0.000 description 1
- 108010083809 Talin Proteins 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000016390 Uvaria chamae Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 241000202221 Weissella Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 235000015190 carrot juice Nutrition 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 235000021185 dessert Nutrition 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229960001275 dimeticone Drugs 0.000 description 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000019674 grape juice Nutrition 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000008944 intestinal immunity Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- 238000004900 laundering Methods 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000011580 nude mouse model Methods 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- UORVCLMRJXCDCP-UHFFFAOYSA-N propynoic acid Chemical compound OC(=O)C#C UORVCLMRJXCDCP-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000012744 reinforcing agent Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/158—Milk preparations; Milk powder or milk powder preparations containing additives containing vitamins or antibiotics
- A23C9/1585—Antibiotics; Bacteriocins; Fungicides from microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
- A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
- A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0204—Specific forms not provided for by any of groups A61K8/0208 - A61K8/14
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
- A61K8/022—Powders; Compacted Powders
- A61K8/0225—Granulated powders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Plant Pathology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明涉及一种包含间歇灭菌的乳酸菌死菌体作为有效成分的用于皮肤保湿或改善皱纹的组合物。检查了间歇灭菌的乳酸菌死菌体对由于紫外线照射而变差的皮肤保湿或改善皱纹的作用。结果证实了其减少从皮肤蒸发的水分量并增加皮肤中所含有的水分量。此外，证实了其减小表皮厚度并降低皱纹相关蛋白质的表达量。因此，本发明的组合物改善由紫外线照射而引起的皮肤屏障的损伤，从而抑制皮肤水分损失或皱纹形成。
Description
技术领域
本发明涉及一种包含间歇灭菌的乳酸菌死菌体作为有效成分的用于皮肤保湿或改善皱纹的组合物。
背景技术
皮肤作为经常接触外部环境的器官，主要起到保护人体远离外部的物理性伤害和化学物质，防止细菌、真菌、病毒等侵入到皮肤内，并防止水分损失的屏障作用。通过观察皮肤结构，可知其由表皮、真皮、皮下脂肪3个层构成，其中表皮作为3个层当中最薄的层，起到负责皮肤保湿和保护的重要作用。特别地，皮肤的弹性和柔润由表皮角质层中存在的水分来维持，并已知为了维持角质层的弹性，必须含有10％以上的水分(O.K.Jacobi，Proc.Sci.Sec.Toilet Goods Assoc.1959，31，22)。
最近，由于环境污染等原因，暴露在强紫外线中的情况变多，随着由此引发的皮肤水分损失的增加，皮肤老化加快，并且随着由皮肤损伤引起的相关疾病发病率的增加，对于能够维持暴露在紫外线下的皮肤的保湿力以及长时间保持改善皱纹效果的组合物的需求具有逐渐增加的趋势。
另外，乳酸菌是一种在人体内起到有益作用的细菌，作为一种通过发酵诸如碳水化合物等糖类来形成乳酸(乳酸)的细菌，迄今为止，已发现了400余种，其中市售可得的有18种。已知这些乳酸菌具有免疫增强作用，特别具有增强胃、肠道免疫的生理活性。最近，由于健康生活的潮流，已经形成了好的食物在擦拭时也会起到好的作用的社会氛围，因此开发出了多种对身体有利的化妆品，其中已报道了乳酸菌的培养液具有皮肤保湿、增加角质层更新速率、缓解皱纹等效果，但是，实际使用化妆品时其效果甚微的情况较多。
例如，韩国专利申请公开第1991-0019600号中公开了一种具有保湿和清除活性氧功能的用于化妆品的乳酸菌培养液的相关技术。韩国专利申请公开第2013-0096604号中公开了一种包含发芽谷物的发酵提取液作为主要成分的发酵化妆品及其制备方法的相关技术，公开了将通过发酵乳酸菌而形成的产物包含在化妆品材料中，或通过将发芽谷物等与特定属的乳酸菌一起发酵而获得的发酵液混合到化妆品材料中以及使用这些材料的技术。此外，已知韩国专利申请公开第2013-0115943号中公开了一种包含乳酸菌裂解上清液的用于抗炎、皮肤美白、和抗老化的组合物的相关技术。但是，在使用乳酸菌活菌时，即使是冷冻干燥的粉末形式也不仅具有吸湿等问题，还依然存在乳酸菌的稳定性等问题以及相关问题。为了解决这些问题，可生产出一种具有均一性能的产品，即本发明的有效成分，其为间歇灭菌的乳酸菌死菌体，由于其可被冷冻干燥并可长期贮存，因此，是有利的。目前还没有间歇灭菌的乳酸菌死菌体的皮肤保湿或改善皱纹效果的相关报道。
发明内容
发明要解决的课题
本发明是一项由如上所述的需求而引出的发明，发明人为了开发用于皮肤保湿或改善皱纹的组合物而进行了研究。结果证实了间歇灭菌的乳酸菌死菌体抑制或减少了由于紫外线照射而引起的皮肤水分的损失，保护皮肤屏障的皮肤保湿效果优异，并证实了其抑制皱纹产生相关的蛋白质MMP-9的表达量。因此完成了本发明。
解决课题的方法
为了实现所述目的，本发明提供一种包含间歇灭菌的乳酸菌死菌体作为有效成分的用于皮肤保湿或改善皱纹的健康功能食品。
此外，本发明提供一种包含间歇灭菌的乳酸菌死菌体作为有效成分的用于皮肤保湿或改善皱纹的化妆品组合物。
此外，本发明提供一种包含间歇灭菌的乳酸菌死菌体作为有效成分的用于皮肤保湿或改善皱纹的药学组合物。
发明的效果
本发明涉及一种包含间歇灭菌的乳酸菌死菌体作为有效成分的用于皮肤保湿或改善皱纹的组合物。本发明的组合物具有抑制或减少由于紫外线照射而引起的皮肤水分损失的皮肤保湿或改善皱纹的效果。并且，本发明的组合物可生产性能均一的产品，并具有可长期贮存的优点。
附图说明
图1为证实间歇灭菌的乳酸菌死菌体抑制经皮水分损失的效果的结果。＊相对于对照组具有显著性(P＜0.0001)；#相对于紫外线照射组具有显著性(P＜0.0001)；CON为对照组；UV为紫外线照射组；Lactob为间歇灭菌的乳酸菌死菌体处理组。
图2为评价间歇灭菌的乳酸菌死菌体的皮肤水分含量的结果。＊相对于对照组具有显著性(P＜0.0001)；#相对于紫外线照射组具有显著性(P＜0.0001)；CON为对照组；UV为紫外线照射组；Lactob为间歇灭菌的乳酸菌死菌体处理组。
图3为通过测量表皮厚度变化而评价改善皱纹效果的结果。＊相对于对照组具有显著性(P＜0.0001)；#相对于紫外线照射组具有显著性(P＜0.0001)；CON为对照组；UV为紫外线照射组；Lactob为间歇灭菌的乳酸菌死菌体处理组。
图4为通过H&E染色而评价改善皱纹效果的结果。对照为正常对照组；媒介物为紫外线照射对照组；Lactob为间歇灭菌的乳酸菌死菌体处理组。
图5为证实间歇灭菌的乳酸菌死菌体的皱纹相关蛋白表达量的结果。CON为对照组；UV为紫外线照射组；Lactob为间歇灭菌的乳酸菌死菌体处理组。
具体实施方式
本发明提供一种包含间歇灭菌的乳酸菌死菌体作为有效成分的用于皮肤保湿或改善皱纹的健康功能食品。
所述乳酸菌优选为选自链球菌属(Streptococcus)、乳球菌属(Lactococcus)、肠球菌属(Enterococcus)、乳杆菌属(Lactobacillus)、片球菌属(Pediococcus)、明串珠菌属(Leuconostoc)、魏斯氏菌属(Weissella)和双歧杆菌属(Bifidobacterium)中的至少一种菌株，但不限于此，更优选为嗜酸乳杆菌(Lactobacillus acidophilus)。
此外，乳酸菌发酵步骤优选为在添加糖类酵母提取物、大豆蛋白胨和离子组分、以及其他生长因子之后将乳酸菌进行发酵的步骤，但不限于此。
所述乳酸菌的间歇灭菌法是一种将活菌乳酸菌灭活的方法，可使用任何已知的间歇灭菌方法，并可购买使用已上市销售的间歇灭菌的乳酸菌死菌体。优选间歇灭菌的乳酸菌死菌体通过以下间歇灭菌法来制备：从发酵培养液中分离乳酸菌发酵菌体后，将乳酸菌发酵菌体在60-160℃的温度下加热10至60分钟，并迅速冷却到20-40℃或20℃进行灭活。
此外，所述间歇灭菌的乳酸菌死菌体优选为冷冻干燥的粉末形式，但不限于此。
所述皮肤保湿是指抑制或减少由于紫外线照射而引起的皮肤水分损失，但不限于此。
本发明的健康功能食品可通过直接添加间歇灭菌的乳酸菌死菌体而制备、或将其与其他食品或食品成分一起制备，并可根据常规方法适当地制备。作为所述可添加间歇灭菌的乳酸菌死菌体的食品的实例，可以是选自焦糖、肉类、香肠、面包、巧克力、糖果类、点心类、饼干、比萨、拉面、其他面类、口香糖类、包含冰淇淋类的乳制品、各种汤、饮料、茶、饮品、酒精饮料以及维生素复合剂中的任意一种，并包含所有一般意义上的健康食品。即，所述食品种类不受特别的限制。
所述健康功能食品可包含各种营养素、维生素、矿物质(电解质)、合成的以及天然的风味剂、着色剂以及增强剂(奶酪、巧克力等)、果胶酸以及其盐、炔酸以及其盐、有机酸、保护性胶体增稠剂、pH调节剂、稳定剂、防腐剂、甘油、醇、用于碳酸饮料的碳酸化剂等。并且，可包含用于制造天然果汁以及蔬菜饮料的果肉。所述成分可单独使用或组合使用。
并且，本发明的健康功能食品可包含多种香味剂或天然糖类作为追加成分，所述天然糖类为诸如葡萄糖、果糖的单糖、诸如麦芽糖、蔗糖的二糖、以及诸如糊精、环糊精的多糖类、诸如木糖醇、山梨糖醇、赤藓糖醇的糖醇。虽然所述天然糖类的比例不是很重要，但相对于100g本发明的健康功能食品，优选包含0.01-0.04g，更优选包含0.02-0.03g，但不限于此。
作为甜味剂可使用诸如索马甜、甜菊提取物的天然甜味剂或诸如糖精、阿斯巴甜的合成甜味剂等。
本发明的健康功能食品除了所述间歇灭菌的乳酸菌死菌体以外可追加包含公知的皮肤健康相关成分。追加包含有助于皮肤健康的原料可进一步增强本发明的健康食品的皮肤保湿或改善皱纹效果。当追加有助于皮肤健康的原料时，应考虑与组合使用相关的皮肤安全性、剂型化的便利性和有效成分的稳定性。
作为所述追加的皮肤保湿或改善皱纹成分可使用已知原料或个别地被韩国食品药品管理局认定为可作为健康功能食品原料的原料。
所述个别认定的原料优选松树皮提取物等的复合物、红参、蛇床子、山茱萸复合提取物、凹唇姜(Finger root)提取物粉末、N-乙酰葡糖胺、透明质酸、魔芋提取物、AP胶原蛋白酶解肽、芝草提取物粉末、蒲公英等的复合提取物、肽，但不限于此。
此外，本发明提供一种包含间歇灭菌的乳酸菌死菌体作为有效成分的用于皮肤保湿或改善皱纹的化妆品组合物。
所述乳酸菌优选为选自链球菌属、乳球菌属、肠球菌属、乳杆菌属、片球菌属、明串珠菌属、魏斯氏菌属和双歧杆菌属中的至少一种菌株，但不限于此，更优选为嗜酸乳杆菌。
并且，乳酸菌发酵步骤优选为添加糖类酵母提取物、大豆蛋白胨和离子组分、以及其他生长因子之后将乳酸菌进行发酵的步骤，但不限于此。
所述乳酸菌的间歇灭菌法是一种将活菌乳酸菌灭活的方法，可使用任何已知的间歇灭菌方法，并可购买使用已上市销售的间歇灭菌的乳酸菌死菌体。优选间歇灭菌的乳酸菌死菌体通过以下间歇灭菌法来制备：从发酵培养液中分离乳酸菌发酵菌体后，将乳酸菌发酵菌体在60-160℃的温度下加热10至60分钟，并迅速冷却到20-40℃或20℃来进行灭活。
此外，所述间歇灭菌的乳酸菌死菌体优选为冷冻干燥的粉末形式，但不限于此。
所述皮肤保湿是指抑制或减少由于紫外线照射而引起的皮肤水分的损失，但不限于此。
本发明的化妆品组合物可以为溶液、凝胶、固体或浆状无水生成物、通过在水相中分散油相而获得的乳状液、悬浮液、微乳状液、微胶囊或离子脂质体、非离子型囊泡分散剂、霜剂、护肤水、润肤露、粉剂、霜剂、精华剂、喷雾剂或遮瑕棒的形式。并且，可制备成泡沫的形式或进一步包含压缩促进剂的气溶胶的形式。
此外，除了本发明的间歇灭菌的乳酸菌死菌体外，所述化妆品组合物可包含脂质、有机溶剂、增溶剂、增稠剂以及胶凝剂、软化剂、抗氧化剂、悬浮剂、稳定剂、发泡剂、芳香剂、表面活性剂、水、离子或非离子型乳化剂、填充剂、金属离子掩蔽剂和螯合剂、防腐剂、维生素、阻滞剂、保湿剂、精油、染料、颜料、亲水性或亲脂性活化剂和脂质囊泡或在化妆品领域中通常使用的辅助剂，如通常用于化妆品的任意其他成分。
在本发明的包含间歇灭菌的乳酸菌死菌体作为有效成分的用于皮肤保湿或改善皱纹的化妆品组合物中，基于化妆品组合物的总重量计，可含有0.01-15重量％、优选2-10重量％的本发明的间歇灭菌的乳酸菌死菌体。
除了所述间歇灭菌的乳酸菌死菌体外，本发明的用于皮肤保湿或改善皱纹的化妆品组合物可追加包含公知的皮肤保湿或改善皱纹成分。追加包含有助于皮肤健康的原料可进一步增进本发明的用于皮肤保湿或改善皱纹的化妆品组合物的效果。当追加有助于皮肤健康的原料时，应考虑与组合使用相关的皮肤安全性、剂型化的便利性和有效成分的稳定性。
此外，本发明提供一种包含间歇灭菌的乳酸菌死菌体作为有效成分的用于皮肤保湿或改善皱纹的药学组合物。
所述乳酸菌优选为选自链球菌属、乳球菌属、肠球菌属、乳杆菌属、片球菌属、明串珠菌属、魏斯氏菌属和双歧杆菌属中的至少一种菌株，但不限于此，更优选为嗜酸乳杆菌。
此外，乳酸菌发酵步骤优选为添加糖类酵母提取物、大豆蛋白胨和离子组分、以及其他长因子之后将乳酸菌进行发酵的步骤，但不限于此。
所述乳酸菌的间歇灭菌法是一种将活菌乳酸菌灭活的方法，可使用任何已知的间歇灭菌方法，并可购买使用已上市销售的间歇灭菌的乳酸菌死菌体。优选间歇灭菌的乳酸菌死菌体通过以下间歇灭菌法来制备：从发酵培养液中分离乳酸菌发酵菌体后，将乳酸菌发酵菌体在60-160℃的温度下加热10至60分钟，并迅速冷却到20-40℃或20℃来进行灭活。
此外，所述间歇灭菌的乳酸菌死菌体优选为冷冻干燥的粉末形式，但不限于此。
本发明的药学组合物为了进行给药，除了上述有效成分以外可追加包含1种以上的药学上可接受的载体来制备。药学上可接受的载体应当能够与本发明的有效成分兼容，可通过混合并使用盐水、无菌水、林格氏溶液、缓冲盐水、右旋糖溶液、麦芽糊精溶液、甘油、乙醇中的至少1种，并根据所需可追加抗氧化剂、缓冲剂、抑菌剂等其他常规添加剂。此外，通过追加稀释剂、分散剂、表面活性剂、粘合剂以及润滑剂而将组合物制成诸如水溶液、悬浮液、乳液等的注射用制剂。
此外，可制成多种剂型如散剂、锭剂、胶囊剂、液剂、注射剂、软膏剂等，并且，可以在单位-剂量或多-剂量容器，例如密封的安剖瓶和小瓶等中提供。
本发明的药学组合物可通过口服或非口服途径给药。本发明的药学组合物的给药途径可为：例如口腔、静脉内、肌肉内、动脉内、骨髓内、膈膜内、心脏内、经皮、皮下、腹腔内、肠管、舌下或局部给药，但不限于此。
为了这样的临床给药，可使用公知技术将本发明的药学组合物制成制剂。本领域技术人员可根据患者的体重、年龄、性别、健康状态、饮食、给药时间、方法、排泄率以及疾病的严重程度等容易地确定本发明的组合物的给药量。
下文中，将使用实施例对本发明进行更详细的说明。这些实施例仅用于更具体地说明本发明，并不限制本发明的范围，这对于本领域技术人员应该是显而易见的。
[材料与方法]
间歇灭菌的乳酸菌死菌体的制备：使用通过以下方法制备的间歇灭菌的乳酸菌死菌体：从发酵培养液中分离嗜酸乳杆菌乳酸菌发酵菌体后，将乳酸菌发酵菌体在120℃下加热30分钟，并急速冷却到20℃以下来进行灭活。
[实验动物与样品给药]
无毛小鼠：从中央实验动物公司购买7周龄的雄性无毛鼠(雄性HR-1，无毛小鼠，Japan SLC Inc.)并在经过1周的适应期后使用。在试验中使用通过在适应期间观察一般状态而被认定为处于健康状态的动物。饲育环境维持在温度23±3℃、湿度50±5％、明暗周期12小时(07：00-19：00/照明时间)。试验期间，每组7只实验动物，给小鼠饲喂小鼠专用饲料5L79(Charles river，USA)并自由进食，使小鼠饮用经紫外线消毒的自来水并自由饮水。
样品给药：实验分为3组：对照组、紫外线处理组(UV)和间歇灭菌的乳酸菌死菌体给药组(Lactob)。样品给药通过小鼠探针进行口服给药。给药时间为总共12周，每周给药5天。
[紫外线照射]
对除了对照组以外的实验组进行持续12周、每周3次的紫外线照射。紫外线使用UVB灯(Mineralight UV Display lamp，UVP，USA)。紫外线照射量如下：1至7周之间为60mJ/cm2、8至12周之间为90mJ/cm2，总共12周。通过光测量仪(Delta OHM，意大利)测量紫外线照射量并调节照射时间。
[保湿效果的评价]
1)经皮水分损失量(TEWL)的评价
经皮水分蒸发量：在恒温、恒湿(23℃、相对湿度50％)条件下通过使用皮肤水份流失测试仪(Tewameter Courage&Khazaka，德国)根据面积和时间计算从皮肤蒸发的水分量，通过保湿电子传感器读取蒸发的水分量(g/m2/hr)，并将其量化来测量皮肤的保湿力。
2)皮肤水分含量的测量
皮肤水分含量：在恒温、恒湿(23℃、相对湿度50％)条件下通过使用皮肤水分测试仪(Corneometer Courage&Khazaka，德国)测量皮肤中的水分含量。通过传感器测量皮肤表皮内存在的水分的离子化程度，通过将其量化并计算水分含量来测量皮肤的保湿力。
[皮肤的组织学观察]
在将无毛小鼠背部皮肤组织剔出并固定在10％的中性福尔马林溶液中之后，根据常规方法经过洗涤、脱水、透明化、渗透过程后，以石蜡进行包埋，并切成4μm厚的切片，之后实施组织染色(Hematoxylin&Eosin；H&E)。
[电泳与蛋白质印迹法]
使用20-30mg皮肤组织，添加提取蛋白质的溶液并进行粉碎，然后分离蛋白质并进行定量，将和对照组(肌动蛋白)相同量的蛋白质进行电泳并移至PVDF膜，然后与抗体进行反应来测量蛋白质的表达量。
[统计方法]
通过使用单因素方差分析以及t检验来分析本发明中获得的结果的对照组和实验组之间的显著性(p＜0.05)。
实施例1.间歇灭菌的乳酸菌死菌体处理组的保湿效果评价
1)经皮水分损失量(TEWL)分析
为了证实保湿效果而在各实验组的无毛小鼠的背部皮肤中实施经皮水分损失量分析。经皮水分损失量是从皮肤散发出的水分量，其数值越高表示皮肤保湿机能越低，表明皮肤固有的屏障功能受到损伤。经皮水分蒸发量的评价通过以下方法进行：在恒温、恒湿(23℃、相对湿度：50％)条件下通过使用皮肤水份流失测试仪(Tewameter Courage&Khazaka，德国)根据面积和时间计算从皮肤蒸发的水分量，通过水分电子传感器读取蒸发的水分量(g/m2/hr)，并将其量化来测量皮肤的保湿力。其结果显示在图1中。如图1所示，可证实紫外线照射造成皮肤屏障功能受损，进而降低了皮肤保湿功能(p＜0.0001)，并证实了通过间歇灭菌的乳酸菌死菌体(Lactob)处理组有效地防止了由于紫外线照射引发的皮肤水分水分损失(p＜0.0001)。
2)皮肤水分含量测量
为了测量皮肤中所含有的水分量而在各实验组的无毛小鼠的背部皮肤中进行皮肤水分含量的分析。结果如图2中所示，证实了紫外线照射组相对于对照组皮肤水分含量下降(p＜0.0001)，间歇灭菌的乳酸菌死菌体处理组相对于紫外线照射组显示出更高的水分含量。基于这样的结果，证实了间歇灭菌的乳酸菌死菌体处理组具有皮肤保湿效果。
实施例2.基于表皮厚度变化的效能评价
通过测量表皮厚度变化而证实抑制皱纹的效能。表皮厚度通过以下方法测量：使用安装在显微镜中的尺子测量经H&E染色的组织的从角质层到表皮基底膜的厚度。根据图3中示出的结果，证实了在紫外线照射时表皮厚度增加，并证实了给予间歇灭菌的乳酸菌死菌体的组表皮厚度降低。
实施例3.基于组织染色的效能评价(H&E染色)
为了证实抑制由紫外线引发的皱纹的效能，脱除无毛小鼠的皮肤组织后，通过组织染色进行证实。如图4中所示，证实了紫外线照射组相对于对照组，角质层和表皮厚度均增加，并了证实在紫外线照射组中，给予间歇灭菌的乳酸菌死菌体的组相对于未给予间歇灭菌的乳酸菌死菌体的紫外线照射组，角质层得到缓解，并且表皮厚度降低。
实施例4.MMP-9(基质金属肽酶9)蛋白质表达量的评价
测量已知对皱纹产生起到重要作用的MMP(基质金属肽酶9)蛋白质表达量。结果如图5中所示，证实了紫外线照射组(UV)相对于未照射试验组(Con)，蛋白质表达量增加，而采用乳酸菌死菌体处理的试验组(Lactob)降低了由于紫外线引起的MMP-9蛋白质的表达量。通过所述结果可确定具有改善由于紫外线而产生的皱纹的效果。
制备例1.包含间歇灭菌的乳酸菌死菌体作为有效成分的用于皮肤保湿或改善皱纹的化妆品组合物的制备
1)柔性化妆水的制备
本发明的含有间歇灭菌的乳酸菌死菌体作为有效成分的柔性化妆水是由以下成分制备的：10.00重量份的间歇灭菌的乳酸菌死菌体、1.00重量份的1，3-丁二醇、0.05重量份的乙二胺四乙酸二钠、0.01重量份的尿囊素、0.05重量份的甘草酸二钾、0.01重量份的柠檬酸、0.02重量份的柠檬酸钠、1.00重量份的甘油醇-26、2.00重量份的熊果苷、1.00重量份的氢化蓖麻油、30.00重量份的乙醇、微量防腐剂、着色剂以及香料、以及余量的净化水。
2)滋养霜的制备
本发明的含有间歇灭菌的乳酸菌死菌体作为有效成分的滋养霜是由以下成分制备的：10.00重量份的间歇灭菌的乳酸菌死菌体、7.0重量份的1，3-丁二醇、1.0重量份的甘油、0.1重量份的D-泛醇、3.2重量份的植物提取物、0.3重量份的硅酸镁铝、1.2重量份的PEG-40硬脂酸酯、2.0重量份的硬脂酸、1.5重量份的聚山梨酯60、2.0重量份的亲脂性硬脂酸甘油酯、1.5重量份的脱水山梨醇倍半油酸酯、3.0重量份的鲸蜡硬脂醇、4.0重量份的矿物油、3.8重量份的角鲨烷、2.8重量份的辛酸/癸酸甘油三酯、1.8重量份的植物油、0.4重量份的二甲硅油、微量甘草酸二钾、微量尿囊素、微量透明质酸钠、适量醋酸生育酚、适量三乙醇胺、适量防腐剂、适量香料以及余量的净化水。
3)精华液的制备
根据下述配比，在80±2℃的条件下称重并将间歇灭菌的乳酸菌死菌体、净化水、对羟基苯甲酸甲酯、透明质酸提取物、甘油混合来制备水相。并且，在80±2℃的条件下称重并将对羟基苯甲酸丙酯、卵磷脂和澳洲坚果油混合来制备油相。之后将所述油相添加到水相中，使两相互相混合来制备乳液形式的混合物，并在所述混合物中添加香料并冷却到35±2℃来制备包含间歇灭菌的乳酸菌死菌体的精华液。
水相由以下成分制成：8.00重量份的间歇灭菌的乳酸菌死菌体、7.58重量份的净化水、0.15重量份的对羟基苯甲酸甲酯、2.50重量份的透明质酸提取物、8.00重量份的甘油。
油相由以下成分制成：0.10重量份的对羟基苯甲酸丙酯、0.60重量份的卵磷脂、10.0重量份的澳洲坚果油；以及0.07重量份的作为添加剂的香料。
制备例2.包含间歇灭菌的乳酸菌死菌体作为有效成分的用于皮肤保湿或改善皱纹的健康功能食品
1)面粉食品的制备
将0.5-5.0重量份的本发明的间歇灭菌的乳酸菌死菌体添加到面粉中，并使用该混合物来制备面包、蛋糕、曲奇、饼干以及面条。
2)乳制品的制备
将5-10重量份的本发明的间歇灭菌的乳酸菌死菌体添加到牛奶中，并使用所述牛奶来制备诸如奶酪以及冰淇淋等的多种乳制品。
3)禅食的制备
将糙米、大麦、大米、薏苡仁以公知的方法进行糊化并干燥，并对其进行焙烧后，以粉碎机制备成粒度为60目的粉末。
将黑豆、黑芝麻、紫苏子也以公知的方法进行干燥，并对其进行焙烧后，以粉碎机制备成粒度为60目的粉末。将本发明的间歇灭菌的乳酸菌死菌体在真空浓缩机中进行减压浓缩后，进行喷雾并采用热风干燥机干燥，将所得干燥物用粉碎机制成粒度为60目的干燥粉末。
将如上制备的谷物类、种子坚果类、以及间歇灭菌的乳酸菌死菌体以下述比率进行调配：谷物类(30重量份的糙米、15重量份的薏苡仁、20重量份的大麦)，种子坚果类(7重量份的紫苏子、8重量份的黑豆、7重量份的黑芝麻)，间歇灭菌的乳酸菌死菌体(3重量份)，灵芝(0.5重量份)，地黄(0.5重量份)。
4)巧克力的制备
以如下配比混合而制备包含间歇灭菌的乳酸菌死菌体的巧克力：30.0重量份的可可豆，30.0重量份的全脂奶粉，41.85重量份的糖粉，0.45重量份的卵磷脂，0.1重量份的香料，0.6重量份的间歇灭菌的乳酸菌死菌体。
5)健康饮料的制备
将诸如液体果糖(0.5％)、低聚糖(2％)、糖(2％)、食盐(0.5％)、水(75％)的辅料和5g本发明的间歇灭菌的乳酸菌死菌体均匀地混合并瞬时灭菌之后，并将其以玻璃瓶、塑料瓶等小包装容器进行包装来制备。
6)蔬菜汁的制备
通过将5g本发明的间歇灭菌的乳酸菌死菌体添加到1000ml西红柿或胡萝卜汁中来制备蔬菜汁。
7)水果汁的制备
通过将1g本发明的间歇灭菌的乳酸菌死菌体添加到1000ml苹果或葡萄汁中来制备水果汁。
Claims (14)
1.一种包含间歇灭菌的乳酸菌死菌体作为有效成分的用于皮肤保湿或改善皱纹的健康功能食品。
2.权利要求1所述的用于皮肤保湿或改善皱纹的健康功能食品，其特征在于：
所述乳酸菌为选自链球菌属、乳球菌属、肠球菌属、乳杆菌属、片球菌属、明串珠菌属、魏斯氏菌属和双歧杆菌属中的至少一种菌株。
3.权利要求1所述的用于皮肤保湿或改善皱纹的健康功能食品，其特征在于：
所述间歇灭菌的乳酸菌死菌体通过以下方法制备：从发酵培养液中分离乳酸菌发酵菌体后，将乳酸菌发酵菌体在60-160℃的温度下加热10至60分钟，并迅速冷却到20-40℃或20℃来进行灭活。
4.一种包含间歇灭菌的乳酸菌死菌体作为有效成分的用于皮肤保湿或改善皱纹的化妆品组合物。
5.权利要求4所述的用于皮肤保湿或改善皱纹的化妆品组合物，其特征在于：
所述乳酸菌为选自链球菌属、乳球菌属、肠球菌属、乳杆菌属、片球菌属、明串珠菌属、魏斯氏菌属和双歧杆菌属中的至少一种菌株。
6.权利要求4所述的用于皮肤保湿或改善皱纹的化妆品组合物，其特征在于：
基于化妆品组合物的总重量计，包含0.01-15重量％的所述间歇灭菌的乳酸菌死菌体。
7.权利要求4所述的用于皮肤保湿或改善皱纹的化妆品组合物，其特征在于：
所述间歇灭菌的乳酸菌死菌体通过以下方法制备：从发酵培养液中分离乳酸菌发酵菌体后，将乳酸菌发酵菌体在60-160℃的温度下加热10至60分钟，并迅速冷却到20-40℃或20℃来进行灭活。
8.权利要求4所述的用于皮肤保湿或改善皱纹的化妆品组合物，其特征在于：
所述间歇灭菌的乳酸菌死菌体为冷冻干燥的粉末形式。
9.权利要求4所述的用于皮肤保湿或改善皱纹的化妆品组合物，其特征在于：
所述皮肤保湿是指抑制或减少由于紫外线照射而引起的皮肤水分损失。
10.权利要求4所述的用于皮肤保湿或改善皱纹的化妆品组合物，其特征在于：
所述化妆品组合物还包含选自脂质、有机溶剂、增溶剂、增稠剂以及胶凝剂、软化剂、抗氧化剂、悬浮剂、稳定剂、发泡剂、芳香剂、表面活性剂、水、离子型或非离子型乳化剂、填充剂、金属离子掩蔽剂和螯合剂、防腐剂、维生素、阻滞剂、保湿剂、精油、染料、颜料、亲水性或亲脂性活化剂和脂质囊泡中至少一种辅助剂。
11.权利要求4至10任一项所述的用于皮肤保湿或改善皱纹的化妆品组合物，其特征在于：
所述化妆品组合物为选自溶液、凝胶、固体或浆状无水生成物、在水相中分散油相而获得的乳状液、悬浮液、微乳状液、微胶囊或离子脂质体、非离子型囊泡分散剂、霜剂、护肤水、润肤露、粉剂、霜剂、精华剂、喷雾剂或遮瑕棒中的任一种剂型。
12.一种包含间歇灭菌的乳酸菌死菌体作为有效成分的用于皮肤保湿或改善皱纹的药学组合物。
13.权利要求12所述的用于皮肤保湿或改善皱纹的药学组合物，其特征在于：
所述乳酸菌为选自链球菌属、乳球菌属、肠球菌属、乳杆菌属、片球菌属、明串珠菌属、魏斯氏菌属和双歧杆菌属中的至少一种菌株。
14.权利要求12所述的用于皮肤保湿或改善皱纹的药学组合物，其特征在于：
所述间歇灭菌的乳酸菌死菌体通过以下方法制备：从发酵培养液中分离乳酸菌发酵菌体后，将乳酸菌发酵菌体在60-160℃的温度下加热10至60分钟，并迅速冷却到20-40℃或20℃来进行灭活。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020140126460A KR101693574B1 (ko) | 2014-09-23 | 2014-09-23 | 틴달화 유산균 사균체를 유효성분으로 포함하는 피부 보습 또는 주름개선용 조성물 |
| KR10-2014-0126460 | 2014-09-23 | ||
| PCT/KR2015/007119 WO2016047907A1 (ko) | 2014-09-23 | 2015-07-09 | 틴달화 유산균 사균체를 유효성분으로 포함하는 피부 보습 또는 주름개선용 조성물 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107105747A true CN107105747A (zh) | 2017-08-29 |
Family
ID=55581395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201580061120.5A Pending CN107105747A (zh) | 2014-09-23 | 2015-07-09 | 包含间歇灭菌的乳酸菌死菌体作为有效成分的用于皮肤保湿或改善皱纹的组合物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20170189327A1 (zh) |
| EP (1) | EP3199036A4 (zh) |
| JP (1) | JP2017534589A (zh) |
| KR (1) | KR101693574B1 (zh) |
| CN (1) | CN107105747A (zh) |
| WO (1) | WO2016047907A1 (zh) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107854417A (zh) * | 2017-11-07 | 2018-03-30 | 广州市汇吉科技企业孵化器有限公司 | 一种抗衰老吸附膜 |
| TWI680772B (zh) * | 2018-02-12 | 2020-01-01 | 景岳生物科技股份有限公司 | 一種植物乳桿菌ｇｍｎｌ－６組合物用於皮膚保健的用途 |
| CN111135136A (zh) * | 2020-03-26 | 2020-05-12 | 广州七遇生物科技有限公司 | 一种抗衰老护肤组合物及其制备方法 |
| CN113425608A (zh) * | 2020-03-23 | 2021-09-24 | 韩国科玛株式会社 | 改善稳定性的含有难溶性有用成分的囊泡组合物及包含其的化妆料组合物 |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2657665B1 (es) * | 2016-09-05 | 2018-12-17 | Pedro Jose DE LA FUENTE BLASCO | Productos para la salud con probióticos inactivados y uso de dichos productos |
| CN106399192A (zh) * | 2016-10-25 | 2017-02-15 | 江苏微康生物科技有限公司 | 一种乳酸菌发酵溶胞产物、制备方法及其应用 |
| KR101939918B1 (ko) * | 2017-09-08 | 2019-01-17 | 신홍식 | 파프리카를 이용한 유산균 발효 방법 및 이의 용도 |
| JP6846376B2 (ja) * | 2018-03-15 | 2021-03-24 | キリンホールディングス株式会社 | 皮膚状態改善用組成物 |
| JP7130330B2 (ja) * | 2018-09-05 | 2022-09-05 | 株式会社ノエビア | 皮膚外用剤 |
| KR102074384B1 (ko) * | 2019-01-28 | 2020-02-06 | 주식회사 락토메이슨 | 신규한 비피도박테리움 애니멀리스 락티스 lm1017을 유효성분으로 포함하는, 주름 개선 및 피부 탄력용 화장료 조성물 |
| WO2020185382A1 (en) * | 2019-03-08 | 2020-09-17 | The Procter & Gamble Company | Structured aqueous compositions having dispersed liquid benefit agent droplets |
| KR102133689B1 (ko) | 2020-02-24 | 2020-07-13 | 에스케이바이오랜드 주식회사 | 용암해수 유래 미네랄과 더마바이오틱스 유래 뉴클레오티드의 결합체 제조방법 및 이를 이용한 기능성 더마바이오틱스 화장품 조성물 |
| KR20200124590A (ko) | 2019-04-24 | 2020-11-03 | 주식회사 지앤피바이오사이언스 | 개다래 추출물을 포함하는 피부 손상 개선용 또는 피부 보습용 조성물 |
| WO2020218890A1 (ko) | 2019-04-24 | 2020-10-29 | 주식회사 지앤피바이오사이언스 | 개다래 추출물을 포함하는 피부 손상 개선용 또는 피부 보습용 조성물 |
| KR20200124628A (ko) | 2019-04-24 | 2020-11-03 | 주식회사 지앤피바이오사이언스 | 개다래 추출물을 포함하는 피부 손상 개선용 또는 피부 보습용 조성물 |
| KR102210621B1 (ko) * | 2019-05-09 | 2021-02-03 | 한국 한의학 연구원 | 페디오코쿠스 이노피나투스를 유효성분으로 포함하는 피부 주름 개선 및 피부 보습용 조성물 |
| KR102118575B1 (ko) * | 2019-05-09 | 2020-06-03 | 한국 한의학 연구원 | 엔테로코쿠스 락티스를 유효성분으로 포함하는 피부 주름 개선 및 피부 보습용 조성물 |
| KR102270939B1 (ko) * | 2019-11-29 | 2021-06-30 | 주식회사 엘리샤코이 | 락토바실러스 아시도필루스 사균체를 유효성분으로 포함하는, 항노화용 화장료 조성물 |
| FR3110414B1 (fr) | 2020-05-19 | 2023-04-21 | Aime Inc | Composition cosmétique comprenant au moins une céramide, au moins un micro-organisme tyndallisé et au moins un bisabolol végétal |
| KR102404383B1 (ko) * | 2020-05-27 | 2022-06-07 | 주식회사 피토메카 | 와이셀라 시바리아 세포 용해물을 포함하는 피부 노화 방지 또는 주름 개선용 화장료 조성물 |
| KR102252855B1 (ko) * | 2020-09-25 | 2021-05-18 | 주식회사 아미코스메틱 | 나노화된 락토바실러스 속 사균체를 포함하는 화장료 조성물 및 이의 제조방법 |
| KR102529325B1 (ko) * | 2020-12-28 | 2023-05-08 | 코스맥스 주식회사 | 바이셀라 시바리아 균주 및 이의 용도 |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20080100095A (ko) * | 2007-05-11 | 2008-11-14 | 주식회사 코리아나화장품 | 락토바실러스 람노서스 유산균주 또는 이의 배양액을함유하는 여드름 개선용 화장료 조성물 |
| EP2050434A1 (en) * | 2006-08-10 | 2009-04-22 | House Wellness Foods Corporation | Moisturizing agent |
| JP2010143885A (ja) * | 2008-12-22 | 2010-07-01 | Asahi Breweries Ltd | 乳酸菌およびそれらを用いた飲食物又は化粧品 |
| WO2011029784A1 (en) * | 2009-09-08 | 2011-03-17 | Giuliani Spa | Probiotic lactobacillus rhamnosus strain and oral and topical uses thereof |
| CN102725397A (zh) * | 2010-11-04 | 2012-10-10 | 细胞生物技术公司 | 用于抗菌的死乳酸菌菌体及其制备方法 |
| CN102762194A (zh) * | 2009-12-08 | 2012-10-31 | 欧莱雅 | 益生菌微生物作为抵抗皮肤纹理变化的活性剂 |
| JP5254682B2 (ja) * | 2008-06-27 | 2013-08-07 | 株式会社ヤクルト本社 | 経口摂取用皮膚性状改善剤 |
| JP2015096476A (ja) * | 2013-11-15 | 2015-05-21 | 株式会社東洋新薬 | コラーゲン産生促進用組成物、コラーゲン吸収促進用組成物、抗肥満用組成物 |
| CN105025908A (zh) * | 2012-12-31 | 2015-11-04 | G·莫格纳 | 针对肿瘤、获得性免疫缺陷综合征和白血病的化疗治疗的支持疗法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3112983B2 (ja) * | 1991-05-31 | 2000-11-27 | 御木本製薬株式会社 | 化粧料 |
| US20050272694A1 (en) * | 2003-03-07 | 2005-12-08 | Aureo Co., Ltd | Composition containing beta-glucan and constipation-relieving drug, immunopotentiatior, and skin moistening agent using the composition |
| JP4000078B2 (ja) * | 2003-03-07 | 2007-10-31 | 株式会社アウレオ | 皮膚用保湿剤 |
| JP2008503563A (ja) * | 2004-06-23 | 2008-02-07 | ロレアル | 敏感及び／又は乾燥肌の予防及び／又は処置に有用な方法及び組成物 |
-
2014
- 2014-09-23 KR KR1020140126460A patent/KR101693574B1/ko active IP Right Grant
-
2015
- 2015-07-09 WO PCT/KR2015/007119 patent/WO2016047907A1/ko active Application Filing
- 2015-07-09 CN CN201580061120.5A patent/CN107105747A/zh active Pending
- 2015-07-09 EP EP15843997.6A patent/EP3199036A4/en not_active Withdrawn
- 2015-07-09 JP JP2017516506A patent/JP2017534589A/ja active Pending
-
2017
- 2017-03-23 US US15/466,914 patent/US20170189327A1/en not_active Abandoned
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2050434A1 (en) * | 2006-08-10 | 2009-04-22 | House Wellness Foods Corporation | Moisturizing agent |
| KR20080100095A (ko) * | 2007-05-11 | 2008-11-14 | 주식회사 코리아나화장품 | 락토바실러스 람노서스 유산균주 또는 이의 배양액을함유하는 여드름 개선용 화장료 조성물 |
| JP5254682B2 (ja) * | 2008-06-27 | 2013-08-07 | 株式会社ヤクルト本社 | 経口摂取用皮膚性状改善剤 |
| JP2010143885A (ja) * | 2008-12-22 | 2010-07-01 | Asahi Breweries Ltd | 乳酸菌およびそれらを用いた飲食物又は化粧品 |
| WO2011029784A1 (en) * | 2009-09-08 | 2011-03-17 | Giuliani Spa | Probiotic lactobacillus rhamnosus strain and oral and topical uses thereof |
| CN102762194A (zh) * | 2009-12-08 | 2012-10-31 | 欧莱雅 | 益生菌微生物作为抵抗皮肤纹理变化的活性剂 |
| CN102725397A (zh) * | 2010-11-04 | 2012-10-10 | 细胞生物技术公司 | 用于抗菌的死乳酸菌菌体及其制备方法 |
| CN105025908A (zh) * | 2012-12-31 | 2015-11-04 | G·莫格纳 | 针对肿瘤、获得性免疫缺陷综合征和白血病的化疗治疗的支持疗法 |
| JP2015096476A (ja) * | 2013-11-15 | 2015-05-21 | 株式会社東洋新薬 | コラーゲン産生促進用組成物、コラーゲン吸収促進用組成物、抗肥満用組成物 |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107854417A (zh) * | 2017-11-07 | 2018-03-30 | 广州市汇吉科技企业孵化器有限公司 | 一种抗衰老吸附膜 |
| TWI680772B (zh) * | 2018-02-12 | 2020-01-01 | 景岳生物科技股份有限公司 | 一種植物乳桿菌ｇｍｎｌ－６組合物用於皮膚保健的用途 |
| CN113425608A (zh) * | 2020-03-23 | 2021-09-24 | 韩国科玛株式会社 | 改善稳定性的含有难溶性有用成分的囊泡组合物及包含其的化妆料组合物 |
| CN113425608B (zh) * | 2020-03-23 | 2024-01-30 | 韩国科玛株式会社 | 改善稳定性的含有难溶性有用成分的囊泡组合物及包含其的化妆料组合物 |
| CN111135136A (zh) * | 2020-03-26 | 2020-05-12 | 广州七遇生物科技有限公司 | 一种抗衰老护肤组合物及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| KR101693574B1 (ko) | 2017-01-06 |
| EP3199036A1 (en) | 2017-08-02 |
| EP3199036A4 (en) | 2018-05-02 |
| WO2016047907A1 (ko) | 2016-03-31 |
| US20170189327A1 (en) | 2017-07-06 |
| KR20160035219A (ko) | 2016-03-31 |
| JP2017534589A (ja) | 2017-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107105747A (zh) | 包含间歇灭菌的乳酸菌死菌体作为有效成分的用于皮肤保湿或改善皱纹的组合物 | |
| US20060233738A1 (en) | Composition for promoting production of type 1 collagen and/or elastin | |
| CN105582036B (zh) | 含有蒲公英提取物的透明质酸生成促进用组合物及其应用 | |
| CN104487061B (zh) | 组合物 | |
| KR102432924B1 (ko) | 식물성 콜라겐 및 식물성 뮤신을 포함하는 추출물 및 조성물 | |
| JP2011088845A (ja) | インボルクリン発現抑制剤 | |
| KR101742542B1 (ko) | 틴달화 유산균 사균체를 유효성분으로 포함하는 피부 보습 또는 주름개선용 조성물 | |
| EP2735304B1 (en) | Composition for preventing or alleviating skin wrinkles containing fermented honeybush extract as an active ingredient | |
| JP2023171950A (ja) | 抗老化剤、抗酸化剤、抗炎症剤、及び美白剤、並びに、化粧料 | |
| JP2007332081A (ja) | 健康美容機能性組成物、それを含有する飲食品および化粧品 | |
| KR102365655B1 (ko) | 콩 발효 추출물을 유효성분으로 포함하는 피부 주름 예방 또는 개선용 조성물 | |
| KR101761125B1 (ko) | 허니부쉬 추출물, 이의 분획물 또는 발효물을 유효성분으로 함유하는 피부 보습용 화장료 조성물 및 건강기능식품 | |
| CN106852725A (zh) | 用于改善皮肤的组合物 | |
| JP4247091B2 (ja) | 皮膚老化防止剤 | |
| KR102176883B1 (ko) | 복사나무 수지를 함유하는 피부 재생, 주름 개선, 또는 상처 치유용 조성물 | |
| TWI794766B (zh) | 含乳酸桿菌之組成物及其預防及/或改善皮膚老化的用途 | |
| KR20160054673A (ko) | 마치현 추출물을 포함하는 히알루론산 생성 촉진용 조성물과 이의 이용 | |
| KR102196051B1 (ko) | 인진쑥 발효물을 포함하는 피부 기능성 조성물 | |
| KR20160054681A (ko) | 원지 추출물을 포함하는 히알루론산 생성 촉진용 조성물과 이의 이용 | |
| KR20160054672A (ko) | 대맥자 추출물을 포함하는 히알루론산 생성 촉진용 조성물과 이의 이용 | |
| KR102401490B1 (ko) | 당귀 추출물을 유효성분으로 함유하는 피부미백 개선 및 자외선 차단용 화장료 조성물 | |
| KR102006665B1 (ko) | 실버위드, 히더, 밀크씨슬의 허브 혼합 추출물을 유효성분으로 함유하는 항산화, 항염, 미백 및 보습 기능성 화장료 조성물 및 그 제조방법 | |
| KR102139827B1 (ko) | 식물성 발효 점액질(mucilase)을 함유한 화장료 조성물 | |
| US20220193163A1 (en) | Composition comprising actinidia polygama extract for alleviating skin damage or moisturizing skin | |
| KR20170136801A (ko) | 피부 상태 개선용 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170829 |
|
| WD01 | Invention patent application deemed withdrawn after publication |